Cutera, Inc. (NASDAQ:CUTR) insider James A. Reinstein sold 7,175 shares of Cutera stock in a transaction that occurred on Tuesday, January 2nd. The stock was sold at an average price of $45.35, for a total transaction of $325,386.25. Following the completion of the transaction, the insider now owns 132,284 shares of the company’s stock, valued at approximately $5,999,079.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Shares of Cutera, Inc. (NASDAQ:CUTR) traded down $1.10 during trading hours on Thursday, hitting $44.25. 222,724 shares of the stock traded hands, compared to its average volume of 222,400. The stock has a market cap of $620.42, a P/E ratio of 59.00, a PEG ratio of 1.35 and a beta of 0.52. Cutera, Inc. has a twelve month low of $17.48 and a twelve month high of $48.95.

Cutera (NASDAQ:CUTR) last issued its quarterly earnings data on Tuesday, November 7th. The medical device company reported $0.42 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.34. The business had revenue of $38.17 million during the quarter, compared to the consensus estimate of $34.82 million. Cutera had a net margin of 7.99% and a return on equity of 18.73%. The company’s revenue was up 26.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.12 EPS. sell-side analysts predict that Cutera, Inc. will post 0.55 earnings per share for the current fiscal year.

A number of research analysts recently issued reports on CUTR shares. BidaskClub upgraded shares of Cutera from a “hold” rating to a “buy” rating in a research note on Tuesday, December 12th. Maxim Group downgraded shares of Cutera from a “buy” rating to a “hold” rating in a research note on Thursday, September 14th. Zacks Investment Research downgraded shares of Cutera from a “hold” rating to a “sell” rating in a research note on Monday. Finally, Roth Capital lifted their price target on shares of Cutera from $41.00 to $47.00 and gave the stock a “buy” rating in a research note on Tuesday, September 12th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have issued a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $37.33.

Several large investors have recently modified their holdings of CUTR. Parallel Advisors LLC purchased a new stake in shares of Cutera during the 3rd quarter worth approximately $117,000. Legal & General Group Plc lifted its position in shares of Cutera by 69.6% during the 3rd quarter. Legal & General Group Plc now owns 3,600 shares of the medical device company’s stock worth $149,000 after buying an additional 1,477 shares during the last quarter. Nationwide Fund Advisors lifted its position in shares of Cutera by 8.4% during the 2nd quarter. Nationwide Fund Advisors now owns 7,216 shares of the medical device company’s stock worth $187,000 after buying an additional 561 shares during the last quarter. Greenwood Capital Associates LLC purchased a new stake in shares of Cutera during the 3rd quarter worth approximately $210,000. Finally, Cubist Systematic Strategies LLC purchased a new stake in shares of Cutera during the 2nd quarter worth approximately $225,000. Institutional investors and hedge funds own 87.64% of the company’s stock.

WARNING: “Insider Selling: Cutera, Inc. (CUTR) Insider Sells 7,175 Shares of Stock” was originally published by American Banking News and is owned by of American Banking News. If you are viewing this article on another domain, it was illegally copied and republished in violation of U.S. and international trademark and copyright law. The legal version of this article can be viewed at https://www.americanbankingnews.com/2018/01/04/insider-selling-cutera-inc-cutr-insider-sells-7175-shares-of-stock.html.

Cutera Company Profile

Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.

Insider Buying and Selling by Quarter for Cutera (NASDAQ:CUTR)

Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.